Effect of bisphosphonates on pain and quality of life in patients with bone metastases
- 3 February 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Clinical Oncology
- Vol. 6 (3), 163-174
- https://doi.org/10.1038/ncponc1323
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Opioid-induced bowel dysfunction: prevalence, pathophysiology and burdenInternational Journal of Clinical Practice, 2007
- The last 3 days of life in three different care settings in The NetherlandsSupportive Care in Cancer, 2007
- Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot studySupportive Care in Cancer, 2007
- Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasiaJournal of Medical Economics, 2007
- The use of bisphosphonates in palliative treatment of bone metastases in a terminally ill, oncological elderly populationArchives of Gerontology and Geriatrics, 2006
- Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and PainJournal of Clinical Oncology, 2003
- Transient relief of metastatic cancer bone pain by oral administration of etidronateJournal of Bone and Mineral Metabolism, 2002
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- Measuring the quality of life of cancer patients: A concise QL-Index for use by physiciansJournal of Chronic Diseases, 1981